These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 30856109)

  • 21. Neuropsychiatric Symptoms Among Hispanics: Results of the Maracaibo Aging Study.
    Gil M; Alliey-Rodriguez N; Lopez-Alvarenga JC; Diego V; Gaona CA; Mata L; Pirela RV; Chavez CA; de Erausquin GA; Melgarejo JD; Maestre GE
    J Alzheimers Dis; 2021; 82(s1):S251-S261. PubMed ID: 33612541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
    Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
    Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
    Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
    Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(9):818-28. PubMed ID: 25323000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient.
    Hsu CC; Wang SI; Lin HC; Lin ES; Yang FP; Chang CM; Wei JC
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
    Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
    J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.
    McDermott KL; Fisher N; Bradford S; Camicioli R
    Int Psychogeriatr; 2018 Feb; 30(2):253-260. PubMed ID: 29094664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Clinical Presentation of Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease According to Sex and Education Level.
    Chang KH; Huang CC; Chen CM; Wu HC; Kuo HC
    J Alzheimers Dis; 2020; 78(2):711-719. PubMed ID: 33044179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Xu L; Li T; Xiong L; Wang X; Ismail Z; Fukuda M; Sun Z; Wang J; Gauthier S; Yu X; Wang H
    J Alzheimers Dis; 2021; 81(3):1141-1149. PubMed ID: 33935092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
    Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
    Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort.
    Nelson RS; Abner EL; Jicha GA; Schmitt FA; Di J; Wilcock DM; Barber JM; Van Eldik LJ; Katsumata Y; Fardo DW; Nelson PT
    Acta Neuropathol Commun; 2023 Jun; 11(1):89. PubMed ID: 37269007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
    Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM
    Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    Dietlin S; Soto M; Kiyasova V; Pueyo M; de Mauleon A; Delrieu J; Ousset PJ; Vellas B
    J Alzheimers Dis; 2019; 70(1):25-34. PubMed ID: 31127783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.
    Yang AN; Wang XL; Rui HR; Luo H; Pang M; Dou XM
    J Nutr Health Aging; 2020; 24(2):237-241. PubMed ID: 32003417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis.
    Mallo SC; Patten SB; Ismail Z; Pereiro AX; Facal D; Otero C; Juncos-Rabadán O
    Ageing Res Rev; 2020 Mar; 58():101004. PubMed ID: 31881368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Burhanullah MH; Tschanz JT; Peters ME; Leoutsakos JM; Matyi J; Lyketsos CG; Nowrangi MA; Rosenberg PB
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):64-71. PubMed ID: 31186157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.